AustCancer progressing with phase IIb Pentrys trial.
In: PharmaWatch: Cancer, Jg. 4 (2005-05-01), Heft 5, S. 6-6
report
Zugriff:
Reports that Australian Cancer Technology Ltd. has reached full recruitment in phase IIb clinical trial of its Pentrys vaccine in patients with hormone-refractory prostate cancer. Overview of the phase IIb study conducted by Cancer Trials Australia; Objective of the company for conducting the study; Comments of the CEO Australian Cancer, Leonard Firestone regarding on the development program for prostate cancer treatment.
Titel: |
AustCancer progressing with phase IIb Pentrys trial.
|
---|---|
Zeitschrift: | PharmaWatch: Cancer, Jg. 4 (2005-05-01), Heft 5, S. 6-6 |
Veröffentlichung: | 2005 |
Medientyp: | report |
Schlagwort: |
|
Sonstiges: |
|